Insight
Defining and addressing medical device user needs
The FDA specifies, “Each manufacturer shall establish and maintain procedures to ensure that the design requirements relating to a device are appropriate and ...
Rotterdam, Netherlands: Today LeQuest announced it has been granted a trademark for the U.S. Market for International Class: 9, 41, 42. This milestone is a major step for LeQuest on its mission to prevent medical errors and improve patient safety by unlocking the full potential of medical staff in the use of medical technology. In response to the increased demand for healthcare training in the U.S., LeQuest is currently expanding its services on a global scale.
LeQuest works with the biggest medical device manufacturers worldwide. The company developed more than 80 simulation-based e-trainings and is active in over 15 global markets.
"We are the leading simulation training platform for medical technology. We are an end-to-end development and delivery partner. Using our e-training allows healthcare professionals to quickly become competent and confident in the use of medical equipment, without travelling and taking expensive equipment offline," according to Peter Rutjes CCO of LeQuest.
Recently LeQuest was recognized in the Netherlands as one the Dutch Tech Hero’s fighting COVID-19 by Techleap.nl because of its support for medical staff throughout this pandemic, including:
- Immediately extending support to medical staff by providing them with the e-training for the Aisys CS2 anesthesia ventilator of GE Healthcare.
- Supporting hospitals with accelerated implementation of new medical equipment.
- Offering ‘crisis essential’ e-training to manufacturers to help them roll-out new equipment to support the scale-up of ICU and hospital capacity.
The U.S. trademark comes at an important time as LeQuest is working on extending its support for improving patient care and safety stateside.
Dr. A. Hamad, an experienced Oncologist at Advocate Health System in the USA, agreed that this out-of-the-ordinary training would benefit medical staff beyond COVID-19.
"This is an unparalleled experience," he said. "They will be more prepared for disaster-type scenarios for the rest of their careers."
LeQuest welcomes the opportunity to create new partnerships and continues to offer its services to American medical staff and medical device manufactures. If you are interested to learn more about how LeQuest can support your education needs, please do not hesitate to reach out.
